Mrs. Ellen C Livingston, LCSW-C, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7303 Hanover Parkway Unit C, Greenbelt, MD 20770 Phone: 301-441-2525 Fax: 301-441-2511 |
Sonia Ross Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 7764 Mandan Rd, Greenbelt, MD 20770 Phone: 301-613-5177 |
Ms. Miesha Damala Scott, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7303 Hanover Parkway, Suite C, Greenbelt, MD 20770 Phone: 301-441-2525 Fax: 301-441-2511 |
Sabriena Mariah Shubert, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7474 Greenway Center Dr Ste 730, Greenbelt, MD 20770 Phone: 301-345-1022 |
Julie Parsons, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7219 Hanover Pkwy Ste D, Greenbelt, MD 20770 Phone: 202-641-3465 |
Bynia Reed, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 7474 Greenway Center Dr, Suite 730, Greenbelt, MD 20770 Phone: 301-982-3437 Fax: 301-982-9452 |
News Archive
States around the country are taking advantage of a once little-used policy that allows them to bill Medicaid for the healthcare expenses of prisoners who leave a correctional institution for treatment. Since 1997, states have been allowed to bill Medicaid for the care of inmates who required treatment at a hospital or nursing facility for longer than 24 hours. The provision has drawn new attention this year as millions of Americans, including those serving time in correctional institutions, have become newly eligible for Medicaid under the Patient Protection and Affordable Care Act (Dickson, 9/23).
Recently, frequency of mastication has dramatically decreased along with changes in dietary habits. Masticatory stimulation has influence on the development of the central nervous system as well as the growth of maxillofacial tissue in children.
CQDM and Ontario Centres of Excellence will fund five highly innovative and unconventional game-changing research and development projects to accelerate drug discovery in the Quebec-Ontario Life Sciences Corridor. Partners are granting $1.5M to Quebec-based and, for the first time, Ontario-based researchers thanks to the partnership with OCE through CQDM's 2014 Explore Program, one of CQDM's flagship programs focusing on early concept validation of cutting-edge technologies that address the most crucial needs in drug discovery and development.
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
Sirnaomics, Inc. announced today that the company has cemented a partnership with a Chinese pharmaceutical company for development of its small interfering RNA (siRNA) therapeutic (STP705) for scarless wound healing.
› Verified 4 days ago